129 related articles for article (PubMed ID: 19509241)
1. Induction of programmed cell death in ErbB2/HER2-expressing cancer cells by targeted delivery of apoptosis-inducing factor.
Mahmud H; Dälken B; Wels WS
Mol Cancer Ther; 2009 Jun; 8(6):1526-35. PubMed ID: 19509241
[TBL] [Abstract][Full Text] [Related]
2. Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas.
von Minckwitz G; Harder S; Hövelmann S; Jäger E; Al-Batran SE; Loibl S; Atmaca A; Cimpoiasu C; Neumann A; Abera A; Knuth A; Kaufmann M; Jäger D; Maurer AB; Wels WS
Breast Cancer Res; 2005; 7(5):R617-26. PubMed ID: 16168106
[TBL] [Abstract][Full Text] [Related]
3. Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction.
Uherek C; Tonn T; Uherek B; Becker S; Schnierle B; Klingemann HG; Wels W
Blood; 2002 Aug; 100(4):1265-73. PubMed ID: 12149207
[TBL] [Abstract][Full Text] [Related]
4. Targeted induction of apoptosis by chimeric granzyme B fusion proteins carrying antibody and growth factor domains for cell recognition.
Dälken B; Giesübel U; Knauer SK; Wels WS
Cell Death Differ; 2006 Apr; 13(4):576-85. PubMed ID: 16179940
[TBL] [Abstract][Full Text] [Related]
5. Selective proapoptotic activity of a secreted recombinant antibody/AIF fusion protein in carcinomas overexpressing HER2.
Yu CJ; Jia LT; Meng YL; Zhao J; Zhang Y; Qiu XC; Xu YM; Wen WH; Yao LB; Fan DM; Jin BQ; Chen SY; Yang AG
Gene Ther; 2006 Feb; 13(4):313-20. PubMed ID: 16267568
[TBL] [Abstract][Full Text] [Related]
6. The proapoptotic activity of C-terminal domain of apoptosis-inducing factor (AIF) is separated from its N-terminal.
Zhang Y; Han T; Zhu Q; Zhang W; Bao W; Fu HJ; Yang J; Huang XJ; Wei JX; Meng YL; Zhao J; Cao YX; Jia LT; Yangi AG
Biol Res; 2009; 42(2):249-60. PubMed ID: 19746271
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of the ErbB2/HER2 tumor antigen to professional APCs results in effective antitumor immunity.
Rohrbach F; Weth R; Kursar M; Sloots A; Mittrücker HW; Wels WS
J Immunol; 2005 May; 174(9):5481-9. PubMed ID: 15843546
[TBL] [Abstract][Full Text] [Related]
8. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
Biburger M; Weth R; Wels WS
J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
[TBL] [Abstract][Full Text] [Related]
9. Dominant cell death induction by extramitochondrially targeted apoptosis-inducing factor.
Loeffler M; Daugas E; Susin SA; Zamzami N; Metivier D; Nieminen AL; Brothers G; Penninger JM; Kroemer G
FASEB J; 2001 Mar; 15(3):758-67. PubMed ID: 11259394
[TBL] [Abstract][Full Text] [Related]
10. Single-chain antibody/activated BID chimeric protein effectively suppresses HER2-positive tumor growth.
Qiu XC; Xu YM; Wang F; Fan QY; Wang LF; Ma BA; Jia LT; Zhao J; Meng YL; Yao LB; Chen SY; Yang AG
Mol Cancer Ther; 2008 Jul; 7(7):1890-9. PubMed ID: 18644999
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of an HER2-specific antibody-toxin fusion protein on human prostate cancer cells.
Wang L; Liu B; Schmidt M; Lu Y; Wels W; Fan Z
Prostate; 2001 Apr; 47(1):21-8. PubMed ID: 11304726
[TBL] [Abstract][Full Text] [Related]
12. Biological properties of a human compact anti-ErbB2 antibody.
De Lorenzo C; Cozzolino R; Carpentieri A; Pucci P; Laccetti P; D'Alessio G
Carcinogenesis; 2005 Nov; 26(11):1890-5. PubMed ID: 15930029
[TBL] [Abstract][Full Text] [Related]
13. [Cloning and expression of recombinant mitochondrial Delta1-120 apoptosis-inducing factor and its enhancive effect on apoptosis of hepatocellular carcinoma cell line SMMC-7721].
Fu YR; Yi ZJ; Yan YR; Qiu ZY
Ai Zheng; 2007 May; 26(5):494-7. PubMed ID: 17672939
[TBL] [Abstract][Full Text] [Related]
14. The effect of direct translocation across endosomes on the cytotoxicity of the recombinant protein e23sFv-Fdt-casp6 to HER2 positive gastric cancer cells.
Ren JL; Meng YL; Hu B; Jia LT; Zhang R; Xu YM; Xie QS; Zhang YQ; Jin BQ; Chen SY; Wang T; Yang AG
Biomaterials; 2011 Oct; 32(30):7641-50. PubMed ID: 21767874
[TBL] [Abstract][Full Text] [Related]
15. [Effect of the truncated human apoptosis-inducing factor expression on apoptosis of HeLa cells].
Yu CJ; Meng YJ; Zhao J; Wang Z; Wang CJ; Yang AG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):10-3. PubMed ID: 15132893
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor and HER2/neu downregulate expression of apoptosis-inducing factor in non-small cell lung cancer.
Chiang YY; Chow KC; Lin TY; Chiang IP; Fang HY
Oncol Rep; 2014 Feb; 31(2):597-604. PubMed ID: 24276579
[TBL] [Abstract][Full Text] [Related]
17. Specific tumoricidal activity of a secreted proapoptotic protein consisting of HER2 antibody and constitutively active caspase-3.
Jia LT; Zhang LH; Yu CJ; Zhao J; Xu YM; Gui JH; Jin M; Ji ZL; Wen WH; Wang CJ; Chen SY; Yang AG
Cancer Res; 2003 Jun; 63(12):3257-62. PubMed ID: 12810656
[TBL] [Abstract][Full Text] [Related]
18. Potent inhibition of human gastric cancer by HER2-directed induction of apoptosis with anti-HER2 antibody and caspase-3 fusion protein.
Zhang DX; Zhao PT; Xia L; Liu LL; Liang J; Zhai HH; Zhang HB; Guo XG; Wu KC; Xu YM; Jia LT; Yang AG; Chen SY; Fan DM
Gut; 2010 Mar; 59(3):292-9. PubMed ID: 19951902
[TBL] [Abstract][Full Text] [Related]
19. Targeted therapy of schwannoma cells in immunocompetent rats with an erbB2-specific antibody-toxin.
Altenschmidt U; Schmidt M; Groner B; Wels W
Int J Cancer; 1997 Sep; 73(1):117-24. PubMed ID: 9334818
[TBL] [Abstract][Full Text] [Related]
20. Life with or without AIF.
Hangen E; Blomgren K; Bénit P; Kroemer G; Modjtahedi N
Trends Biochem Sci; 2010 May; 35(5):278-87. PubMed ID: 20138767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
